Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, ABL, Akebia, Amarin, Biom, Cara, Curevo, Eisai, Genmab, Horizon, I-Mab, Incyte, Intellia, JCR, Karyopharm, Merck, Moleculin, Myovant Sciences, PTC, RDIF, Stoke, Tiziana, Tetra, Vifor.